KITLG and Alzheimer disease: In the third trial, the AD-Con group spent less time in zone 5 searching for the platform compared to the Normal-C group, and the AD-SCF group had a duration that fell between the Normal-C and AD-Con groups (p < 0.05; Figure 4C).